Balanced news tone
News Sentiment
AZN1N sentiment intelligence
AstraZeneca PLC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
54
Balanced news tone
18 relevant articles
News tone and price action are not far from neutral.
86/100 classification confidence.
directly relevant articles
high-authority source matches
-1.8% over one week, -7.9% over four weeks, trend inactive, and near fair-value range.
Why is AstraZeneca stock down today?
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
86/100 classification
One-week reaction
-1.8%
Price digesting
Trend fit
Trend inactive
-7.9% over four weeks
Fair value
5.2%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
3
Neutral
15
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Traders Union
Direct company coverage
Why is AstraZeneca stock down today?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Traders Union
Traders Union
Direct company coverage
AstraZeneca stock price forecast: GBX13,613 resistance as AZN trades flat
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 22 Jun 2026 07:00
- Source
- Traders Union
Traders Union
Direct company coverage
What is behind AstraZeneca stock's recent drop in value today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- Traders Union
Traders Union
Direct company coverage
AstraZeneca stock trades flat as GLP-1 elecoglipron advances to Phase III trials
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- Traders Union
Traders Union
Direct company coverage
GBX13,649 resistance caps AstraZeneca stock as price tests key level
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Traders Union
Reuters
Direct company coverage
AstraZeneca shares dip after US regulatory panel rejects breast cancer drug
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 01 May 2026 07:00
- Source
- Reuters
Reuters
Direct company coverage
AstraZeneca shares drop after US regulators vote against breast cancer drug
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Reuters
Invezz
Direct company coverage
AstraZeneca stock jumps as COPD drug trial win surprises market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Mar 2026 07:00
- Source
- Invezz
Pharmaceutical Executive
Direct company coverage
Former AstraZeneca Executive Charged with Several Offenses in China
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Feb 2026 08:00
- Source
- Pharmaceutical Executive
Reuters
Direct company coverage
AstraZeneca sees steady growth ahead on strong cancer drug demand
- Tone
- Positive 82/100
- Event
- Macro sensitivity
- Published
- 11 Feb 2026 08:00
- Source
- Reuters
fDi Intelligence
Direct company coverage
AstraZeneca bets big on China
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Feb 2026 08:00
- Source
- fDi Intelligence
Reuters
Direct company coverage
AstraZeneca to delist from Nasdaq, join NYSE in February
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jan 2026 08:00
- Source
- Reuters
The Times of India
Direct company coverage
Nasdaq-100 reshuffle: Walmart set to join US stock market index; to replace AstraZeneca from January 20
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jan 2026 08:00
- Source
- The Times of India
Mexico Business News
Direct company coverage
AstraZeneca Expands in Mexico as Kimberly-Clark Acquires Kenvue
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Nov 2025 08:00
- Source
- Mexico Business News
Mexico Business News
Direct company coverage
AstraZeneca Expands Guadalajara Innovation Hub
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Nov 2025 08:00
- Source
- Mexico Business News
Reuters
Direct company coverage
AstraZeneca's US listing may pull other firms from London in its wake
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Oct 2025 07:00
- Source
- Reuters
Mexico Business News
Direct company coverage
AstraZeneca Invests US$30 Million in Innovation Center in Jalisco
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2025 07:00
- Source
- Mexico Business News
Reuters
Direct company coverage
AstraZeneca shares rise as China probe update reassures
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 06 Feb 2025 08:00
- Source
- Reuters